The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer

被引:126
|
作者
Behrens, P [1 ]
Rothe, M [1 ]
Wellmann, A [1 ]
Krischler, J [1 ]
Wernert, N [1 ]
机构
[1] Univ Bonn, Inst Pathol, D-53105 Bonn, Germany
来源
JOURNAL OF PATHOLOGY | 2001年 / 194卷 / 01期
关键词
breast; carcinoma; pre-invasive; carcinogenesis; stroma induction; Ets-1;
D O I
10.1002/path.844
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The first steps of stroma generation are of pivotal importance for carcinogenesis because at this stage are initiated both angiogenesis, the prerequisite for continuous tumour growth, and the proliferation of stromal fibroblasts, These developments contribute to the onset of tumour invasion by secreting several matrix-degrading proteases, Both angiogenesis and the production of proteases are tightly controlled at several levels; of significant importance is transcription, The Ets-1 transcription factor transactivates several genes encoding matrix-degrading proteases and is thought to be involved in both tumour vascularization and invasion. This study therefore investigated, by in situ hybridization and immunohistochemistry, the expression of Ets-1 and of two of its target genes, encoding matrix metalloproteinase (MMP) 1 and MMP9, in order to demonstrate a topographical in vivo correlation between the expression of these three genes during breast cancer formation. All three genes were first expressed within both endothelial cells and stromal fibroblasts during the onset of stroma generation around intraductal and intralobular in situ carcinomas and they mere significantly up-regulated in the stroma of invasive ductal and lobular canters. The results of this study further support the suggested in vivo role of Ets-1 for both angiogenesis and tumour invasion, via matrix-degrading proteases which are already expressed during the early stages of breast carcinogenesis. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 50 条
  • [21] Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer
    Span, PN
    Manders, P
    Heuvel, JJ
    Thomas, CMG
    Bosch, RR
    Beex, LV
    Sweep, CGJ
    ONCOGENE, 2002, 21 (55) : 8506 - 8509
  • [22] Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer
    Paul N Span
    Peggy Manders
    Joop J Heuvel
    Chris MG Thomas
    Remko R Bosch
    Louk VAM Beex
    CGJ (Fred) Sweep
    Oncogene, 2002, 21 : 8506 - 8509
  • [23] ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element
    Wilson, LA
    Gemin, A
    Espiritu, R
    Singh, G
    FASEB JOURNAL, 2005, 19 (12): : 2085 - +
  • [24] Invasive tumors induce c-ets1 transcription factor expression in adjacent stroma
    Calmels, TPG
    Mattot, V
    Wernert, N
    Vandenbunder, B
    Stehelin, D
    BIOLOGY OF THE CELL, 1995, 84 (1-2) : 53 - 61
  • [25] Dihydroartemisinin enhances VEGFR1 expression through up-regulation of ETS-1 transcription factor
    Niu, Na
    Yu, Changmei
    Li, Liqun
    Liu, Qiang
    Zhang, Wenqian
    Liang, Kaili
    Zhu, Youming
    Li, Jing
    Zhou, Xia
    Tang, Jinbao
    Liu, Ju
    JOURNAL OF CANCER, 2018, 9 (18): : 3366 - 3372
  • [26] Ets-1和MMP-9在胎膜早破中的表达和意义
    陈春莹
    李丽
    黄海玉
    陈曼诗
    中国妇幼保健, 2012, 27 (24) : 3796 - 3798
  • [27] Matrix metalloproteinase MMP1 and MMP9 genes expression in breast cancer tissue
    Mohammadian, Hassan
    Sharifi, Rasoul
    Amirdehi, Somayyeh Rezanezhad
    Taheri, Elham
    Bedoustani, Ahmad Babazadeh
    GENE REPORTS, 2020, 21
  • [28] STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell
    Jung, HH
    Lee, J
    Kim, JH
    Ryu, KJ
    Kang, SA
    Park, C
    Sung, K
    Nam, DH
    Kang, WK
    Park, K
    Im, YH
    FEBS LETTERS, 2005, 579 (18) : 3941 - 3946
  • [29] Ets-1 is transcriptionally up-regulated in hypoxia in vivo and in vitro and promotes cell cycle progression of renal tubules.
    Terada, Y
    Tanaka, H
    Okado, T
    Inoshita, S
    Kuwahara, M
    Sato, Y
    Sasaki, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 346A - 347A
  • [30] Gene therapy using ets-1 transcription factor decoy for peritoneal dissemination of gastric cancer
    Taniguchi, Hirokazu
    Fujiwaral, Yoshiyuki
    Dokil, Yuichiro
    Ita, Yurika Su
    Sohma, Itsuro
    Miyata, Hiroshi
    Takiguchi, Shuji
    Yasuda, Takushi
    Tomita, Naruya
    Morishita, Ryuichi
    Monden, Morito
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (07) : 1609 - 1617